Standard steroid treatment for autoimmune pancreatitis.

Abstract:

OBJECTIVE:To establish an appropriate steroid treatment regimen for autoimmune pancreatitis (AIP). METHODS:A retrospective survey of AIP treatment was conducted in 17 centres in Japan. The main outcome measures were rate of remission and relapse. RESULTS:Of 563 patients with AIP, 459 (82%) received steroid treatment. The remission rate of steroid-treated AIP was 98%, which was significantly higher than that of patients without steroid treatment (74%, 77/104; p<0.001). Steroid treatment was given for obstructive jaundice (60%), abdominal pain (11%), associated extrapancreatic lesions except the biliary duct (11%), and diffuse enlargement of the pancreas (10%). There was no relationship between the period necessary to achieve remission and the initial dose (30 mg/day vs 40 mg/day) of prednisolone. Maintenance steroid treatment was given in 377 (82%) of 459 steroid-treated patients, and steroid treatment was stopped in 104 patients. The relapse rate of patients with AIP on maintenance treatment was 23% (63/273), which was significantly lower than that of patients who stopped maintenance treatment (34%, 35/104; p = 0.048). From the start of steroid treatment, 56% (55/99) relapsed within 1 year and 92% (91/99) relapsed within 3 years. Of the 89 relapsed patients, 83 (93%) received steroid re-treatment, and steroid re-treatment was effective in 97% of them. CONCLUSIONS:The major indication for steroid treatment in AIP is the presence of symptoms. An initial prednisolone dose of 0.6 mg/kg/day, is recommend, which is then reduced to a maintenance dose over a period of 3-6 months. Maintenance treatment with low-dose steroid reduces but dose not eliminate relapses.

journal_name

Gut

journal_title

Gut

authors

Kamisawa T,Shimosegawa T,Okazaki K,Nishino T,Watanabe H,Kanno A,Okumura F,Nishikawa T,Kobayashi K,Ichiya T,Takatori H,Yamakita K,Kubota K,Hamano H,Okamura K,Hirano K,Ito T,Ko SB,Omata M

doi

10.1136/gut.2008.172908

subject

Has Abstract

pub_date

2009-11-01 00:00:00

pages

1504-7

issue

11

eissn

0017-5749

issn

1468-3288

pii

gut.2008.172908

journal_volume

58

pub_type

杂志文章,多中心研究

相关文献

GUT文献大全
  • Transit through the gut measured by analysis of a single stool.

    abstract::A method is described for measuring transit time through the gut which requires the collection of only one stool. A dose of 20 radio-opaque markers is given to the subject on each of three consecutive days with breakfast, each dose of marker being of a different type. The first stool passed after rising on the fourth ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.17.3.219

    authors: Cummings JH,Wiggins HS

    更新日期:1976-03-01 00:00:00

  • Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study.

    abstract:BACKGROUND:Because hepatic cirrhosis is a major risk factor for hepatocellular carcinoma, recent guidelines by the European Association for the Study of the Liver (EASL) on clinical management of hepatocellular carcinoma recommend periodic ultrasound surveillance of cirrhotic patients with immediate workup for nodules ...

    journal_title:Gut

    pub_type: 杂志文章,多中心研究

    doi:10.1136/gut.2003.032359

    authors: Caturelli E,Solmi L,Anti M,Fusilli S,Roselli P,Andriulli A,Fornari F,Del Vecchio Blanco C,de Sio I

    更新日期:2004-09-01 00:00:00

  • T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.

    abstract:BACKGROUND AND AIMS:Many lines of evidence suggest that T helper cell type 1 (Th1) immune responses predominate in Crohn's disease (CD). Recently, a novel transcription factor T-box expressed in T cells (T-bet) has been reported as the master regulator of Th1 development. This study was designed to investigate the role...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.2003.024190

    authors: Matsuoka K,Inoue N,Sato T,Okamoto S,Hisamatsu T,Kishi Y,Sakuraba A,Hitotsumatsu O,Ogata H,Koganei K,Fukushima T,Kanai T,Watanabe M,Ishii H,Hibi T

    更新日期:2004-09-01 00:00:00

  • Chemoprevention of colorectal cancer.

    abstract::Colorectal cancer is the fourth commonest form of cancer in men with 678 000 estimated new cases per year worldwide, representing 8.9% of all new cancers. The disease is most frequent in Occidental countries and particularly so in North America, Australia, New Zealand, and parts of Europe. Prospects for colorectal can...

    journal_title:Gut

    pub_type: 杂志文章,评审

    doi:10.1136/gut.43.4.578

    authors: Langman M,Boyle P

    更新日期:1998-10-01 00:00:00

  • Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.

    abstract::Earlier studies regarding possible primary immune disturbances participating in the pathogenesis of Crohn's disease yielded conflicting results. Peripheral blood lymphocyte subsets and lymphocyte proliferative responses to five soluble recall antigens and to the polyclonal stimulator phythaemagglutinin were therefore ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.35.12.1728

    authors: D'Haens G,Hiele M,Rutgeerts P,Geboes K,Ceuppens JL

    更新日期:1994-12-01 00:00:00

  • Human calcitonin stimulates salivary amylase output in man.

    abstract::Salivary amylase output in man increases after injection of synthetic human calcitonin. This effect is dose dependent. ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.17.8.620

    authors: Drack GT,Koelz HR,Blum AL

    更新日期:1976-08-01 00:00:00

  • Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.

    abstract:OBJECTIVE:Gluten-free diet (GFD) is the only management for coeliac disease (CD). Available methods to assess GFD compliance are insufficiently sensitive to detect occasional dietary transgressions that may cause gut mucosal damage. We aimed to develop a method to determine gluten intake and monitor GFD compliance in p...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2015-310148

    authors: Moreno ML,Cebolla Á,Muñoz-Suano A,Carrillo-Carrion C,Comino I,Pizarro Á,León F,Rodríguez-Herrera A,Sousa C

    更新日期:2017-02-01 00:00:00

  • Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.

    abstract::Gastric acid secretion, pepsin secretion, and fasting serum gastrin levels were measured in 23 patients with duodenal ulcer disease, divided into three groups which received either cimetidine 800 mg daily, cimetidine 1600 mg daily, or ranitidine hydrochloride 300 mg daily for eight weeks. Pentagastrin tests were carri...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.24.1.61

    authors: Mohammed R,Holden RJ,Hearns JB,McKibben BM,Buchanan KD,Crean GP

    更新日期:1983-01-01 00:00:00

  • Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.

    abstract:BACKGROUND:The mechanisms of aspirin induced gastroduodenal injury are not fully understood. Aspirin induces the release of reactive oxygen metabolites in animal models, which may contribute to mucosal injury. AIMS:To investigate the effects of aspirin administered with placebo or antioxidants on gastric mucosal react...

    journal_title:Gut

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1136/gut.38.4.518

    authors: McAlindon ME,Muller AF,Filipowicz B,Hawkey CJ

    更新日期:1996-04-01 00:00:00

  • Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera.

    abstract::Human cholera is associated with an increased luminal release of prostaglandin E2 (PGE2), but whether inhibition of increased PGE2 synthesis will reduce or control intestinal secretion is uncertain. 'Steady state' perfusions (10 ml/minute) in 12 patients with acute cholera, and repeat perfusions in nine of these patie...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.33.5.643

    authors: Van Loon FP,Rabbani GH,Bukhave K,Rask-Madsen J

    更新日期:1992-05-01 00:00:00

  • The risk of subsequent primary cancers after colorectal cancer in southeast England.

    abstract:BACKGROUND:Multiple cancers may occur in an individual because of a genetic predisposition, environmental exposure, cancer therapy, or immunological deficiency. Colorectal cancer is one of the most commonly diagnosed cancers, and inherited factors play an important role in its aetiology. AIMS:To characterise the occur...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.50.5.647

    authors: Evans HS,Møller H,Robinson D,Lewis CM,Bell CM,Hodgson SV

    更新日期:2002-05-01 00:00:00

  • Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study.

    abstract::Forty patients with endoscopically proven persistent duodenal ulcer who had been treated for six weeks with cimetidine (1 g/day) were randomly allocated to receive a further six weeks' treatment with cimetidine (1 g/day) or ranitidine (300 mg/day). Ulcers healed in 12 of 19 patients given cimetidine (63%) and in 13 of...

    journal_title:Gut

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1136/gut.25.10.1113

    authors: Quatrini M,Basilisco G,Bianchi PA

    更新日期:1984-10-01 00:00:00

  • Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

    abstract:OBJECTIVES:Roux-en-Y gastric bypass (RYGB) has greater efficacy for weight loss in obese patients than gastric banding (BAND) surgery. We hypothesise that this may result from different effects on food hedonics via physiological changes secondary to distinct gut anatomy manipulations. DESIGN:We used functional MRI, ea...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2013-305008

    authors: Scholtz S,Miras AD,Chhina N,Prechtl CG,Sleeth ML,Daud NM,Ismail NA,Durighel G,Ahmed AR,Olbers T,Vincent RP,Alaghband-Zadeh J,Ghatei MA,Waldman AD,Frost GS,Bell JD,le Roux CW,Goldstone AP

    更新日期:2014-06-01 00:00:00

  • Early gastric cancer in Europe.

    abstract::Despite mass population screening and an incidence of EGC in Japan that is at least double that of the West, there seem to be no genuine differences in the clinicopathological features of the disease between the two regions. The macroscopic appearance, size, depth of invasion, frequency of lymph node invasion, and his...

    journal_title:Gut

    pub_type: 杂志文章,评审

    doi:10.1136/gut.41.2.142

    authors: Everett SM,Axon AT

    更新日期:1997-08-01 00:00:00

  • Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract.

    abstract::Glycosylation is a key modification of proteins and lipids and is involved in most intermolecular and intercellular interactions. The gastrointestinal mucus gel is continuous and can be divided into two layers: a secreted loosely associated layer and a layer firmly attached to the mucosa. In addition, the membrane-bou...

    journal_title:Gut

    pub_type: 杂志文章,评审

    doi:10.1136/gut.2010.212704

    authors: Moran AP,Gupta A,Joshi L

    更新日期:2011-10-01 00:00:00

  • RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours.

    abstract:OBJECTIVE:We aimed at the identification of genetic alterations that may functionally substitute for CTNNB1 mutation in ß-catenin-activated hepatocellular adenomas (HCAs) and hepatocellular carcinoma (HCC). DESIGN:Large cohorts of HCA (n=185) and HCC (n=468) were classified using immunohistochemistry. The mutational s...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-317632

    authors: Longerich T,Endris V,Neumann O,Rempel E,Kirchner M,Abadi Z,Uhrig S,Kriegsmann M,Weiss KH,Breuhahn K,Mehrabi A,Weber TF,Wilkens L,Straub BK,Rosenwald A,Schulze F,Brors B,Froehling S,Pellegrino R,Budczies J,Schirmac

    更新日期:2019-07-01 00:00:00

  • A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.

    abstract:BACKGROUND:Non-selective cyclooxygenase (COX) inhibitors (non-steroidal anti-inflammatory drugs) inhibit large bowel carcinogenesis in patients with familial adenomatous polyposis (FAP). Their role in the duodenum of these patients is less certain. The disease modifying activity of specific COX-2 inhibitors has not bee...

    journal_title:Gut

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1136/gut.50.6.857

    authors: Phillips RK,Wallace MH,Lynch PM,Hawk E,Gordon GB,Saunders BP,Wakabayashi N,Shen Y,Zimmerman S,Godio L,Rodrigues-Bigas M,Su LK,Sherman J,Kelloff G,Levin B,Steinbach G,FAP Study Group.

    更新日期:2002-06-01 00:00:00

  • Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions.

    abstract::A 24 hour gastric aspiration study was carried out on nine Polya gastrectomy, eight pernicious anaemia, and nine matched control subjects. Intragastric pH, bacteria, nitrite, and N-nitroso compounds were assessed half hourly whilst ambulant and hourly when in bed. Both total and nitrate reducing bacterial counts were ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.27.5.491

    authors: Hall CN,Darkin D,Brimblecombe R,Cook AJ,Kirkham JS,Northfield TC

    更新日期:1986-05-01 00:00:00

  • Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.

    abstract::Daytime intragastric pH, fasting and meal stimulated serum gastrin and nocturnal acid output were studied in eight male duodenal ulcer patients before, during and two days after completing nizatidine 300 mg nocte (20:00 h) for four weeks. Median nocturnal acid output (mmol/10 h) decreased during treatment to 11.6 (ran...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.30.4.449

    authors: Fullarton GM,McLauchlan G,Macdonald A,Crean GP,McColl KE

    更新日期:1989-04-01 00:00:00

  • Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells.

    abstract::The staining of HLA class II antigens, the presence of cells positive for interleukin-2 receptors, the proportion of crypt cells in mitosis in the jejunal biopsy specimens, and the dose of coeliac disease marker HLA-DQ genes were studied in 75 healthy family members of coeliac disease patients. Eleven had silent coeli...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.35.1.55

    authors: Holm K,Savilahti E,Koskimies S,Lipsanen V,Mäki M

    更新日期:1994-01-01 00:00:00

  • Blockade of the integrin alphaLbeta2 but not of integrins alpha4 and/or beta7 significantly prolongs intestinal allograft survival in mice.

    abstract:BACKGROUND:Small bowel transplantation remains a difficult therapeutic option endangered by a high rate of rejection and infectious complications. To improve these clinical results, it is mandatory to set up animal models to test alternative immunosuppressive regimens which may lead to immunotolerance. AIMS:To determi...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.47.1.97

    authors: Sarnacki S,Auber F,Crétolle C,Camby C,Cavazzana-Calvo M,Müller W,Wagner N,Brousse N,Révillon Y,Fischer A,Cerf-Bensussan N

    更新日期:2000-07-01 00:00:00

  • Recent advances in the endoscopic management of variceal bleeding.

    abstract::For the first time the endoscopist has more than one option for the management of gastro-oesophageal varices. It is now feasible to select the appropriate therapy on the basis of the clinical setting. Acute injection sclerotherapy remains a quick and simple technique for the control of active bleeding from oesophageal...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.36.5.647

    authors: Williams SG,Westaby D

    更新日期:1995-05-01 00:00:00

  • Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.

    abstract:BACKGROUND AND AIMS:Teduglutide, a GLP-2 analogue, may restore intestinal structural and functional integrity by promoting repair and growth of the mucosa and reducing gastric emptying and secretion, thereby increasing fluid and nutrient absorption in patients with short bowel syndrome (SBS). This 24-week placebo-contr...

    journal_title:Gut

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1136/gut.2010.218271

    authors: Jeppesen PB,Gilroy R,Pertkiewicz M,Allard JP,Messing B,O'Keefe SJ

    更新日期:2011-07-01 00:00:00

  • Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.

    abstract::In a Danish multicentre trial we compared the relapse preventing effects of olsalazine and sulphasalazine in patients with ulcerative colitis over a 12 month treatment period. Two hundred and twenty seven patients (118 men) with at least two previous attacks of ulcerative colitis were randomly allocated according to a...

    journal_title:Gut

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1136/gut.33.2.252

    authors: Kiilerich S,Ladefoged K,Rannem T,Ranløv PJ

    更新日期:1992-02-01 00:00:00

  • Concentration of selenium in plasma and erythrocytes during total parenteral nutrition in Crohn's disease.

    abstract::Plasma- and erythrocyte-selenium concentrations were determined in five consecutive patients with Crohn's disease given preoperative total parenteral nutrition - nil per os - for a mean period of 34 days per patient. No blood components were administered during the total parenteral nutrition. Before the total parenter...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.26.1.50

    authors: Jacobson S,Plantin LO

    更新日期:1985-01-01 00:00:00

  • Modulation of human dendritic cell phenotype and function by probiotic bacteria.

    abstract:BACKGROUND:"Probiotic" bacteria are effective in treating some inflammatory bowel diseases. However which bacteria confer benefit and mechanisms of action remain poorly defined. Dendritic cells, which are pivotal in early bacterial recognition, tolerance induction, and shaping of T cell responses, may be central in med...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.2003.037325

    authors: Hart AL,Lammers K,Brigidi P,Vitali B,Rizzello F,Gionchetti P,Campieri M,Kamm MA,Knight SC,Stagg AJ

    更新日期:2004-11-01 00:00:00

  • Reduced mucosal antimicrobial activity in Crohn's disease of the colon.

    abstract:OBJECTIVES:In order to maintain the mucosal barrier against luminal microorganisms the intestinal epithelial cells synthesise various broad-spectrum antimicrobial peptides including defensins and cathelicidins. Recent studies indicate that both may be deficient in Crohn's disease. To elucidate the possible functional c...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.2006.118646

    authors: Nuding S,Fellermann K,Wehkamp J,Stange EF

    更新日期:2007-09-01 00:00:00

  • Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.

    abstract:BACKGROUND:In some infants with liver disease, 3-oxo-delta 4 bile acids are the major bile acids in urine, a phenomenon attributed to reduced activity of the delta 4-3-oxosteroid 5 beta-reductase required for synthesis of chenodeoxycholic acid and cholic acid. These patients form a heterogeneous group. Many have a know...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.38.4.623

    authors: Clayton PT,Mills KA,Johnson AW,Barabino A,Marazzi MG

    更新日期:1996-04-01 00:00:00

  • Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.

    abstract:OBJECTIVE:Colorectal cancer (CRC) leads to significant morbidity/mortality worldwide. Defining critical research gaps (RG), their prioritisation and resolution, could improve patient outcomes. DESIGN:RG analysis was conducted by a multidisciplinary panel of patients, clinicians and researchers (n=71). Eight working gr...

    journal_title:Gut

    pub_type: 杂志文章,评审

    doi:10.1136/gutjnl-2017-315333

    authors: Lawler M,Alsina D,Adams RA,Anderson AS,Brown G,Fearnhead NS,Fenwick SW,Halloran SP,Hochhauser D,Hull MA,Koelzer VH,McNair AGK,Monahan KJ,Näthke I,Norton C,Novelli MR,Steele RJC,Thomas AL,Wilde LM,Wilson RH,Tomlins

    更新日期:2018-01-01 00:00:00

  • Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer.

    abstract:BACKGROUND:Colonoscopic surveillance for hereditary non-polyposis colorectal cancer (HNPCC) reduces death rates, but early interval cancers still occur, probably due to missed small, aggressive adenomas. Narrow band imaging (NBI), a novel endoscopic technology, highlights superficial mucosal capillaries and improves co...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gut.2007.128926

    authors: East JE,Suzuki N,Stavrinidis M,Guenther T,Thomas HJ,Saunders BP

    更新日期:2008-01-01 00:00:00